VKTX · Viking Therapeutics, Inc. · Documents
$24.40
-1.43 (-5.54%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$2.85B
Shares
116.65M
Volume · Oct 23
4.68M
Avg daily vol (3M)
4.59M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2023-07-26 | 2023-06-30 | |
| 8-K | — | 2023-07-26 | — | |
| S-3ASR | — | 2023-07-26 | — | |
| 8-K | — | 2023-06-14 | 2023-06-13 | |
| 8-K | — | 2023-05-11 | 2023-05-09 | |
| ARS | — | 2023-05-01 | 2022-12-31 | |
| DEF 14A | — | 2023-05-01 | — | |
| DEFA14A | — | 2023-05-01 | — | |
| 8-K | — | 2023-04-26 | — | |
| 10-Q | — | 2023-04-26 | 2023-03-31 | |
| PRE 14A | — | 2023-04-17 | — | |
| 8-K | — | 2023-04-03 | — | |
| 8-K | — | 2023-03-31 | 2023-03-29 | |
| 8-K | — | 2023-03-28 | — | |
| 8-K | — | 2023-03-28 | — | |
| 10-K | — | 2023-02-10 | 2022-12-31 | |
| 8-K | — | 2023-02-08 | — | |
| 8-K | — | 2022-10-26 | — | |
| 10-Q | — | 2022-10-26 | 2022-09-30 | |
| 10-Q | — | 2022-07-27 | 2022-06-30 | |
| 8-K | — | 2022-07-27 | — | |
| 8-K | — | 2022-05-26 | 2022-05-24 | |
| 8-K | — | 2022-04-27 | — | |
| 10-Q | — | 2022-04-27 | 2022-03-31 | |
| DEF 14A | — | 2022-04-07 | 2022-05-24 | |
| DEFA14A | — | 2022-04-07 | — | |
| 8-K | — | 2022-02-09 | — | |
| 10-K | — | 2022-02-09 | 2021-12-31 | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K | — | 2021-07-28 | — | |
| 8-K | — | 2021-07-28 | — | |
| 10-Q | — | 2021-07-28 | 2021-06-30 | |
| S-3 | — | 2021-07-28 | — | |
| 8-K | — | 2021-05-21 | 2021-05-20 | |
| 10-Q | — | 2021-04-28 | 2021-03-31 | |
| 8-K | — | 2021-04-28 | — | |
| DEF 14A | — | 2021-04-08 | 2021-05-20 | |
| DEFA14A | — | 2021-04-08 | — | |
| 8-K | — | 2021-02-17 | — | |
| 10-K | — | 2021-02-17 | 2020-12-31 | |
| 8-K | — | 2021-01-06 | 2021-01-04 | |
| 8-K | — | 2020-10-28 | — | |
| 10-Q | — | 2020-10-28 | 2020-09-30 | |
| 10-Q | — | 2020-07-29 | 2020-06-30 | |
| 8-K | — | 2020-07-29 | — | |
| 8-K | — | 2020-05-21 | — | |
| DEFA14A | — | 2020-05-20 | — | |
| 8-K | — | 2020-04-30 | — | |
| 10-Q | — | 2020-04-30 | 2020-03-31 |
Showing 51–100 of 104 filings
Key facts
CIK
1607678
CUSIP
92686J106
13F (30d)
71 filings
71 filers
Visit website
Investor relations